People
Team Science
Currently sixty-five scientists, most recruited from leading biotechnology and pharmaceutical companies, drive programs in metabolism, epigenetics, and signaling toward the singular goal of developing novel therapies for patients. Collectively, IACS team members have more than 200 years of industry experience, as well as proven track records of effectively translating targets into clinically effective treatments that are in late stage clinical trials, plus one FDA approved agent..
IACS project teams seamlessly integrate drug discovery and target biology research, as well as leverage the clinical and basic science expertise and infrastructure available at MD Anderson. Merging scientific cultures into cross-functional teams that integrate multiple specialized scientific disciplines leads to increased productivity and innovation. Project teams are nimble and accountable driving projects from hypothesis through proof-of-concept to development.
Newsletter
MD Anderson Hightlights
Conquest: IACS Infographic
Cancer Frontline: Institute of Medicine Elects Lynda Chin to Membership
Promise: Academia Meets Biotech in New Institute
Promise: Ronald DePinho Announces IACS
Conquest: Academic Insight, Industrial Execution
Cancerwise: Institute to Bring New Hope for Better Cancer Drugs
External Media Coverage
IACS Established
Governor’s press release
KUT
Houston Chronicle
Boston Globe
GSK Collaboration Announced
FierceBiotech
Drug Discovery News
Houston Business Journal
KUHF Radio Interview
BioWorld
Moon Shot Program Launched
Time Magazine: Cancer Dream Teams
Time Magazine: The Conspiracy To End Cancer
NDC Established
Houston Chronicle
Drug Discovery News
Houston Business Journal
Join our Team
Find your place on our dynamic team.
Contact Us
Institute for Applied Cancer Science
MD Anderson Cancer Center
1901 East Road
Houston TX 77054
Tel: 713-745-2600
For questions concerning collaborations or partnerships, please contact:
Eric Devroe
Executive Director of Strategic Alliances
EJDevroe@mdanderson.org
We need your help
Philanthropic support will provide IACS several critical advantages that will ultimately benefit cancer patients by providing them with novel treatments in a shorter timeframe. If you’re interested in advancing this transformative venture, please donate through the myGiving site.